6C9G
AMP-activated protein kinase bound to pharmacological activator R739
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | APS BEAMLINE 21-ID-D |
Synchrotron site | APS |
Beamline | 21-ID-D |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2016-11-11 |
Detector | DECTRIS EIGER X 9M |
Wavelength(s) | 1.0 |
Spacegroup name | P 61 2 2 |
Unit cell lengths | 122.986, 122.986, 406.048 |
Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
Resolution | 49.556 - 2.700 |
R-factor | 0.2049 |
Rwork | 0.202 |
R-free | 0.24010 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 4rer |
RMSD bond length | 0.006 |
RMSD bond angle | 0.954 |
Data reduction software | iMOSFLM |
Data scaling software | Aimless |
Phasing software | PHASER |
Refinement software | PHENIX (1.9_1692) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 50.000 | 2.780 |
High resolution limit [Å] | 2.700 | 2.700 |
Rmerge | 0.181 | 0.024 |
Number of reflections | 51131 | 4351 |
<I/σ(I)> | 18.7 | |
Completeness [%] | 100.0 | |
Redundancy | 28.3 | |
CC(1/2) | 0.999 | 0.829 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION | 293 | 0.1 M tri-sodium acetate pH 5.6, 0.2 M ammonium acetate, 15% w/v PEG 4000 |